Published in J Allergy Clin Immunol on March 01, 2002
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Impact of asthma controller medications on clinical, economic, and patient-reported outcomes. Mayo Clin Proc (2009) 1.05
Cohorts in economic comparison might not have been comparable. J Allergy Clin Immunol (2002) 0.75
Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective. Value Health (2005) 1.50
Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care (2005) 1.22
Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J Neurosci (2011) 1.18
Neuronal activity and glutamate uptake decrease mitochondrial mobility in astrocytes and position mitochondria near glutamate transporters. J Neurosci (2014) 0.97
Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs. Chem Biol Interact (2010) 0.94
In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs. Chem Biol Interact (2010) 0.88
Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial. Eur J Cardiovasc Prev Rehabil (2005) 0.87
Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 National Health and Nutrition Examination Survey. Am Heart J (2005) 0.86
Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma. Chest (2002) 0.84
Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. J Mol Neurosci (2009) 0.81
Patterns and effectiveness of lipid-lowering therapies in a managed care environment. Value Health (2005) 0.81
Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Toxicol Mech Methods (2009) 0.80
LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results. Curr Med Res Opin (2008) 0.79
In vivo oxime administration does not influence Ellman acetylcholinesterase assay results. Toxicol Mech Methods (2009) 0.78